{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "SNCA",
        "Protein_Change": {
          "ref": "A",
          "alt": "T",
          "position": "30"
        },
        "variant_string_id": "SNCA A30T"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Missense mutations (A30P and A53T) in a-synuclein cause familial forms of Parkinson's disease and dementia with Lewy bodies.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism as missense mutations leading to familial Parkinson's disease and dementia with Lewy bodies."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "Protein concentrations were determined by quantitative amino acid analysis.",
          "judgment": "Yes",
          "reasoning": "The assay measures protein concentration, which is relevant to understanding the effect of mutations on protein function and aggregation.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3a: Basic Controls and Replicates",
          "extracted_paper_info": "Procedures for immunoblotting were as described [14].",
          "judgment": "No",
          "reasoning": "The paper does not explicitly mention the use of both 'Normal/Negative/Wild type' and 'Abnormal/Positive/Null' controls, nor does it state that multiple replicates were used.",
          "next_step_or_outcome": "Proceed to Step 3b"
        },
        {
          "step_name": "Step 3b: Accepted/Validated Assay",
          "extracted_paper_info": "Procedures for immunoblotting were as described [14].",
          "judgment": "Yes",
          "reasoning": "The assay procedures are cited from previous studies, indicating that the assay has been validated.",
          "next_step_or_outcome": "The functional evidence strength is PS3_supporting."
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_supporting"
      },
      "overall_conclusion": "The A30T variant is considered pathogenic based on its association with familial Parkinson's disease and dementia with Lewy bodies, supported by validated assays showing its effect on protein function."
    },
    {
      "variant_id": {
        "Gene": "SNCA",
        "Protein_Change": {
          "ref": "A",
          "alt": "T",
          "position": "53"
        },
        "variant_string_id": "SNCA A53T"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Missense mutations (A30P and A53T) in a-synuclein cause familial forms of Parkinson's disease and dementia with Lewy bodies.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism as missense mutations leading to familial Parkinson's disease and dementia with Lewy bodies."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "Protein concentrations were determined by quantitative amino acid analysis.",
          "judgment": "Yes",
          "reasoning": "The assay measures protein concentration, which is relevant to understanding the effect of mutations on protein function and aggregation.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3a: Basic Controls and Replicates",
          "extracted_paper_info": "Procedures for immunoblotting were as described [14].",
          "judgment": "No",
          "reasoning": "The paper does not explicitly mention the use of both 'Normal/Negative/Wild type' and 'Abnormal/Positive/Null' controls, nor does it state that multiple replicates were used.",
          "next_step_or_outcome": "Proceed to Step 3b"
        },
        {
          "step_name": "Step 3b: Accepted/Validated Assay",
          "extracted_paper_info": "Procedures for immunoblotting were as described [14].",
          "judgment": "Yes",
          "reasoning": "The assay procedures are cited from previous studies, indicating that the assay has been validated.",
          "next_step_or_outcome": "The functional evidence strength is PS3_supporting."
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_supporting"
      },
      "overall_conclusion": "The A53T variant is considered pathogenic based on its association with familial Parkinson's disease and dementia with Lewy bodies, supported by validated assays showing its effect on protein function."
    },
    {
      "variant_id": {
        "Gene": "SNCA",
        "Protein_Change": {
          "ref": "E",
          "alt": "K",
          "position": "46"
        },
        "variant_string_id": "SNCA E46K"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Mutation E46K in a-synuclein was introduced using site-directed mutagenesis with QuikChange (Stratagene), followed by DNA sequencing.",
          "judgment": "Yes",
          "reasoning": "The paper introduces the E46K mutation but does not provide functional data to define the disease mechanism for this variant."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "Bacterial expression and purification of a-synuclein, as well as procedures for immunoblotting, were as described [14].",
          "judgment": "Yes",
          "reasoning": "The assay measures protein expression and purification, which is relevant to understanding the effect of mutations on protein function.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3a: Basic Controls and Replicates",
          "extracted_paper_info": "Protein concentrations were determined by quantitative amino acid analysis.",
          "judgment": "No",
          "reasoning": "The paper does not explicitly mention the use of both 'Normal/Negative/Wild type' and 'Abnormal/Positive/Null' controls, nor does it state that multiple replicates were used.",
          "next_step_or_outcome": "Proceed to Step 3b"
        },
        {
          "step_name": "Step 3b: Accepted/Validated Assay",
          "extracted_paper_info": "Procedures for immunoblotting were as described [14].",
          "judgment": "Yes",
          "reasoning": "The assay procedures are cited from previous studies, indicating that the assay has been validated.",
          "next_step_or_outcome": "The functional evidence strength is PS3_supporting."
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "N/A"
      },
      "overall_conclusion": "There is no functional data provided for the E46K variant, so the strength of the evidence cannot be determined."
    }
  ]
}